Biden administration may expand student loan forgiveness plan

Biden administration may expand student loan forgiveness plan

U.S. President Joe Biden speaks to United Auto Workers members at the UAW’s Community Action Program legislative conference in Washington, D.C., on Jan. 24, 2024. Leah Millis | Reuters The Biden administration announced on Wednesday that it will try to deliver student loan forgiveness to borrowers experiencing financial hardship. After the Supreme Court struck down … Read more

Red Sea freight rate inflation may be peaking already

Red Sea freight rate inflation may be peaking already

Camille Delbos/art In All Of Us | Corbis News | Getty Images The sharp, sudden spike in supply chain inflation caused by the Red Sea crisis and ongoing attacks on shipping vessels by Houthi rebels may have peaked on key global trade routes, based on analysis of the latest data from Xeneta, a leading ocean … Read more

FBI shut down China ‘Volt Typhoon’ hackers targeting U.S.

FBI shut down China ‘Volt Typhoon’ hackers targeting U.S.

The FBI shut down a major China-backed hacking group that attacked hundreds of routers and had been working to compromise U.S. cyber infrastructure, FBI Director Christopher Wray announced Wednesday at a House committee hearing. The hacking group, code-named “Volt Typhoon,” had compromised hundreds of office and home-office routers to allow the Chinese government to access … Read more

Starbucks’ earnings report was weak — but Wall Street expected worse

Starbucks’ earnings report was weak — but Wall Street expected worse

A customer exits a Starbucks store in Manhattan on Jan. 30, 2024, in New York City. Spencer Platt | Getty Images Wall Street is shaking off Starbucks’ weak quarterly report, seemingly taking executives at their word that the company’s challenges are “transitory.” The coffee giant’s stock ticked higher in morning trading, hours after it reported … Read more

Oil poised for best month since September

Oil poised for best month since September

Oil prices are on pace for the first monthly gain since September as the U.S. and Iran stand on the brink of a more direct confrontation in the Middle East. The West Texas Intermediate contract for March was last down $1.09, or 1.40%, to trade at $76.73 a barrel on Wednesday. The Brent contract for … Read more

Tech earnings not impressing Wall Street

Tech earnings not impressing Wall Street

The Nasdaq MarketSite in New York, June 9, 2023. Michael Nagle | Bloomberg | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like what you see? You can subscribe here. What … Read more

Tech earnings not good enough for Wall Street

Tech earnings not good enough for Wall Street

A trader works on the floor of the New York Stock Exchange Michael Nagle | Bloomberg | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like what you see? You … Read more

World’s No. 1 shipper pleads with Congress to help end Houthi ‘chaos’

World’s No. 1 shipper pleads with Congress to help end Houthi ‘chaos’

A cargo ship crosses the Suez Canal, one of the most critical human-made waterways, in Ismailia, Egypt on December 29, 2023.  Fareed Kotb | Anadolu | Getty Images The world’s largest shipping company, MSC, and several retail and trade experts warned Congress on Tuesday that if the Red Sea chaos caused by Houthi rebel attacks … Read more

Vertex non-opioid painkiller shows positive late-stage trial results

Vertex non-opioid painkiller shows positive late-stage trial results

A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Vertex Pharmaceuticals on Tuesday said its experimental painkiller, which is being tested as an alternative to addictive opioids, significantly decreased post-surgery pain in late-stage trials The drug, known as VX-548, did not work … Read more

J&J, Merck and Bristol Myers Squibb in the hot seat

J&J, Merck and Bristol Myers Squibb in the hot seat

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com.  Three names in the industry – Johnson & Johnson, Merck and Bristol Myers Squibb – face a pivotal few weeks … Read more